Alia Therapeutics
Pre-clinicalAlia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases
Founded
2019
Focus
Drug Delivery
About
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases
Funding History
3Total raised: $33.5M
Series A$20MSofinnova PartnersMar 15, 2023
Seed$10MSofinnova PartnersJun 15, 2022
Seed$3.5MSofinnova PartnersJun 15, 2021
Company Info
TypePrivate
Founded2019
LocationTrento, Italy
StagePre-clinical
Contact
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile